Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Krauss (Giessen, Germany), J. Zoelitz (Giessen, Germany), J. Wagner (Giessen, Germany), G. Barretto (Bad Nauheim, Germany), M. Degen (Greifenstein, Germany), W. Seeger (Giessen, Germany), A. Guenther (Giessen, Germany). The use of electronic nose technology for the detection of Lung Cancer (LC): analysis of exhaled volatile compounds by Aeonose®. 1758

Member's Comments

No comment yet.

Related content which might interest you: Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 The research on early detection of lung cancer with exhaled volatile organic compounds Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Detection of lung cancer by analysis of exhaled breath: from sniffing dogs to modern mass-spectrometric techniques Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Design of accurate COPD classification model based on volatile organic compounds from exhaled air Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Standardization of exhaled volatile organic compounds (VOCs) measurement Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Detection of lung cancer using expired breath analysis by ion mobility spectrometry Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Feasibility of using multiplex technology for simultaneous quantification of inflammatory proteins in exhaled particles Source: International Congress 2016 – Phenotyping asthma Year: 2016 Future perspectives on exhaled biomarkers Source: Eur Respir Monogr 2010; 49: 237-246 Year: 2010 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016